Mohamed Ashour, Abdallah Tageldein Mansour, Yousef A Alkhamis, Mostafa Elshobary
{"title":"Usage of <i>Chlorella</i> and diverse microalgae for CO<sub>2</sub> capture - towards a bioenergy revolution.","authors":"Mohamed Ashour, Abdallah Tageldein Mansour, Yousef A Alkhamis, Mostafa Elshobary","doi":"10.3389/fbioe.2024.1387519","DOIUrl":null,"url":null,"abstract":"<p><p>To address climate change threats to ecosystems and the global economy, sustainable solutions for reducing atmospheric carbon dioxide (CO<sub>2</sub>) levels are crucial. Existing CO<sub>2</sub> capture projects face challenges like high costs and environmental risks. This review explores leveraging microalgae, specifically the <i>Chlorella</i> genus, for CO<sub>2</sub> capture and conversion into valuable bioenergy products like biohydrogen. The introduction section provides an overview of carbon pathways in microalgal cells and their role in CO<sub>2</sub> capture for biomass production. It discusses current carbon credit industries and projects, highlighting the <i>Chlorella</i> genus's carbon concentration mechanism (CCM) model for efficient CO<sub>2</sub> sequestration. Factors influencing microalgal CO<sub>2</sub> sequestration are examined, including pretreatment, pH, temperature, irradiation, nutrients, dissolved oxygen, and sources and concentrations of CO<sub>2</sub>. The review explores microalgae as a feedstock for various bioenergy applications like biodiesel, biooil, bioethanol, biogas and biohydrogen production. Strategies for optimizing biohydrogen yield from <i>Chlorella</i> are highlighted. Outlining the possibilities of further optimizations the review concludes by suggesting that microalgae and <i>Chlorella</i>-based CO<sub>2</sub> capture is promising and offers contributions to achieve global climate goals.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368733/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2024.1387519","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
To address climate change threats to ecosystems and the global economy, sustainable solutions for reducing atmospheric carbon dioxide (CO2) levels are crucial. Existing CO2 capture projects face challenges like high costs and environmental risks. This review explores leveraging microalgae, specifically the Chlorella genus, for CO2 capture and conversion into valuable bioenergy products like biohydrogen. The introduction section provides an overview of carbon pathways in microalgal cells and their role in CO2 capture for biomass production. It discusses current carbon credit industries and projects, highlighting the Chlorella genus's carbon concentration mechanism (CCM) model for efficient CO2 sequestration. Factors influencing microalgal CO2 sequestration are examined, including pretreatment, pH, temperature, irradiation, nutrients, dissolved oxygen, and sources and concentrations of CO2. The review explores microalgae as a feedstock for various bioenergy applications like biodiesel, biooil, bioethanol, biogas and biohydrogen production. Strategies for optimizing biohydrogen yield from Chlorella are highlighted. Outlining the possibilities of further optimizations the review concludes by suggesting that microalgae and Chlorella-based CO2 capture is promising and offers contributions to achieve global climate goals.
期刊介绍：
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
